Background
==========

The most frequent complaint for which patients seek treatment from primary care physicians in the United States is cough \[[@B1]\]. Type, frequency and diurnal changes of cough may be criteria for differential diagnosis, therapeutic efficacy, and a gauge for the progression of chronic disease. Historically, cough evaluation has been difficult and of limited clinical value due to a lack of surveillance tools to assess cough frequency completely and its impact on health-related quality of life (HRQL).

To date, methods used to assess cough have been primarily subjective, and only broadly reflect the impact of chronic cough and/or chronic cough therapies on quality of life \[[@B2]-[@B5]\]. These methods have been unable to offer substantial information related to the minimal reduction in cough frequency necessary to achieve a significant improvement in HQRL. Objective assessment of cough has been attempted, but these techniques were neither ambulatory nor feasible for long-term data collection \[[@B6]-[@B8]\]. Other systems have evaluated sound to quantify cough frequency and intensity with moderate success \[[@B9],[@B10]\], but have been limited in their effectiveness outside the laboratory and requires labor intensive analysis and interpretation \[[@B11]-[@B15]\].

We evaluated a novel ambulatory cardio-respiratory monitoring system with an integrated unidirectional, contact microphone, and report here the results from a study of patients with COPD who were videotaped in a quasi-controlled environment for 24 continuous hours while wearing the ambulatory system.

Methods
=======

Subjects
--------

Eight subjects with chronic obstructive pulmonary disease (COPD) who complained of cough as a prominent symptom (e.g., ten or greater self reported bouts of cough per day) were recruited for the study. Subjects were men and women over the age of 40 who had a documented medical history of COPD and a smoking history of ≥ 10 years with chronic productive cough. Patient characteristics can be found in Table [1](#T1){ref-type="table"}. Patients were excluded from the study if, upon screening, (1) it was determined from patient medical history that cough could be due to other known causes such as gastro-esophageal reflux, asthma, or any anatomical abnormalities of the upper respiratory tract, and/or (2) if patients were using prescribed or over the counter anti-tussive medications within 24-hours of the start of the study.

###### 

Patient characteristics. Values are means ± SD; Ht = height; Wt = weight; BMI = Body mass index; %FEV~1~= % predicted forced expiratory volume in one second; n = 8 (6 women)

  Variable        
  --------------- -------------
  Age (yrs)       57.4 ± 11.8
  Ht (cm)         165.4 ± 7.2
  Wt (kg)         76.1 ± 14.4
  BMI (kg/m^2^)   27.8 ± 4.7
  %FEV~1~         49.6 ± 13.7

The protocol was approved by an independent ethical review board (Western IRB, 3535 7th Avenue SW, Olympia, WA, USA, 98502) and all patients received a verbal and written description of the study and gave informed consent prior to participation. All data were collected under the medical supervision of board certified pulmonologists.

Instrumentation and monitoring
------------------------------

### LifeShirt^®^System

Patients were fitted with the wearable LifeShirt^®^system (LS, VivoMetrics, Inc., Ventura, CA, USA), which incorporates respiratory inductance plethysmography (RIP) for the non-invasive measurement of volume and timing ventilatory variables and has been described elsewhere \[[@B15]-[@B22]\]. The system also incorporates a unidirectional contact microphone, a single channel ECG, and a centrally located, 3-axis accelerometer. Data were processed and stored on a compact flash card that was housed within the recorder unit. Patients were invited to wear the LS system for a maximum of 24 hours.

Video surveillance
------------------

Patients spent the testing period in an assigned room where the video monitoring equipment was installed. Patients were monitored via video recorder camera (low-lux) with unidirectional free-air microphone for the duration of the testing period. The video data stream was synchronized to the LS data stream by the coordination of the device clocks. The LS recorder has an on-board electronic diary which creates an event time stamp in the LS software data stream which was referenced to the video data time display to determine the beginning of the recording period. Patients were allowed free range of the research facility and were permitted to watch television, use the telephone, dine, take breaks and sleep.

Data analysis and statistics
----------------------------

Raw physiologic data records were uploaded to a centralized data center and were visually inspected for quality by technicians. 94.1% of the data were interpretable and available for comparison to video. Specialized software (VivoLogic^®^, VivoMetrics, Inc., Ventura, CA, USA) was used to view the LS data and a proprietary algorithm housed within the software was used to identify cough from the physiologic recordings. LS data were visually inspected by two independent reviewers who remained blinded to the video data. Each noted the time (hour, minute and second) of each cough. These data were captured into a spreadsheet. Cough events (hour, minute, second, millisecond) identified by the LS software were exported into a separate spreadsheet. A practical extraction and report language (PERL) script was written to temporally align the two data streams so that the output from each device could be compared for agreement on an event by event basis.

To summarize the validity and reliability of the ambulatory system to detect cough under several conditions, six validation and agreement measures were used including, sensitivity (SN), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), accuracy and kappa \[[@B23]\] were calculated relative to video rating. The PPV is the probability that a patient coughed, if the system judged the respiratory event as a cough. Likewise, the NPV is the probability that the patient did not cough, given that the system did not judge the event as a cough. Accuracy is the proportion of all correct tests. The method used to calculate the confidence intervals was the Wilson score method without continuity correction \[[@B24]\], which has been previously shown to exhibit a logit scale symmetry property with consequent log scale symmetry for certain derived intervals \[[@B25]\].

Results
=======

A satisfactory fit of the available standard sizes of the respiratory inductance plethysmography (RIP) garment was achieved in all patients and the system was well tolerated during the recording period. Figure [1](#F1){ref-type="fig"} and Figure [2](#F2){ref-type="fig"} depict a representative recording of a single cough during quiet breathing and during a series of coughs close together, respectively. Figure [3](#F3){ref-type="fig"} is a representative recording of speech.

![**Representative recording of a single cough followed by a throat clear during quiet breathing**. V~T~= tidal volume; F~b~= breathing frequency; Mic = contact microphone output; SE = sound envelope; HR = heart rate; ECG = electrocardiograph tracing; Posture = body position defined as upright, supine, right decubitis and left decubitis; Cough = cough output from algorithm. The shaded bar contains the cough event. Cough is indicated by a single solid line at the end of the breath that contains the cough. Note the change in the posture from supine to upright to supine immediately following the cough. Entire duration of depicted recording is 1-min and 1-sec.](1745-9974-1-3-1){#F1}

![**Representative recording of coughing during sleep**. V~T~= tidal volume; F~b~= breathing frequency; Mic = contact microphone output; SE = sound envelope; HR = heart rate; ECG = electrocardiograph tracing; Posture = body position defined as upright, supine, right decubitis and left decubitis; Cough = cough output from LS algorithm. The first shaded bar contains the cough bout. Ten coughs occurred during the 9-sec bout. Each cough is indicated by a single solid line at the end of the breath that contains the cough. Note that the cough bout was followed by a 15-sec apnea (second shaded bar). Entire duration of depicted recording is 1-min and 23-sec.](1745-9974-1-3-2){#F2}

![**Representative recording of talking and laughing**. V~T~= tidal volume; F~b~= breathing frequency; Mic = contact microphone output; SE = sound envelope; HR = heart rate; ECG = electrocardiograph tracing; Posture = upright. The shaded bar contains a burst of laughing. Entire duration of depicted recording is 1-min and 37-sec.](1745-9974-1-3-3){#F3}

Patients were invited to be observed for a maximum of 24 hours. A total of 109 hours of simultaneous recordings of video and LS were obtained. Of that time, 73.9 hours were observed during the day and 34.7 hours were observed during the night. During the recording period, the total number of coughs documented by video surveillance was 3,645. The LS system reported 3,363 coughs during the same time period. The median cough rate per patient was 21.3 coughs·hr^-1^(Range: 10.1 cghs·hr^-1^-- 59.9 cghs·hr^-1^).

Table [2](#T2){ref-type="table"} provides performance summaries for the LS system to detect cough during for night vs. day and for low and high respiration rates, respectively. Patients were assigned to low vs. high respiratory rate depending on whether the rate was below or above the median breathing frequency (median F~b~= 21 br·min^-1^). The system was highly accurate in identifying cough as a respiratory event during night or day. Accuracy during the night was 99.4%, while accuracy during the day was 98.8% for a difference = 0.53%. The specificities and negative predictive values are considered \'excellent\' by the criteria proposed by Byrt (1996)\[[@B26]\]. Sensitivities, positive predictive values and kappa can be considered \'very good\' by the same criteria. Likewise, the performance summaries for the system between high or low respiration rates were remarkably similar. Accuracy, specificities, and negative predictive values were \'excellent\' and sensitivities, positive predictive values and kappa were \'very good\' \[[@B26]\].

###### 

Validation and agreement statistics (with 95% confidence intervals) for the LifeShirt system during day & night and at low & high respiration rates. Values are calculated values for the sensitivity (SN), specificity (SP), positive predictive-value (PPV), negative predictive-value (NPV), accuracy (ACC) and the kappa statistic. Values in parentheses are the 95% confidence intervals. All values are for LS system compared to video documentation of cough events; \* p-value \< 0.0001 for night vs. day comparisons of period for SN, SP, NPV and ACC; ¶p-value \< 0.0001 for night vs. day comparisons of respiratory rate for SN, SP, PPV, NPV; ‡ p-value = 0.004 for day vs. night comparisons of respiratory rate for ACC. Day period defined as 0600--1800; Night period defined as 1800--0600. Patients were assigned to the low or high respiratory rate group based on whether their mean F~b~was below or above the median F~b~(median = 21 br·min^-1^).

                                  **Period**          **Respiratory Rate**                       
  ----------- ------------------- ------------------- ---------------------- ------------------- ---------------------
  **SN**      78.1 (76.7, 79.4)   76.7 (75.1, 78.2)   82.7 (80.0, 85.1)\*    69.5 (66.3, 72.6)   80.6 (79.0, 82.0)¶
  **SP**      99.6 (99.5, 99.6)   99.6 (99.5, 99.6)   99.7 (99.7, 99.8)\*    99.5 (99.5, 99.6)   99.7 (99.6, 99.7) ¶
  **PPV**     84.6 (83.3, 85.8)   84.5 (83.0, 85.8)   85.0 (82.3, 87.3)      69.8 (66.5, 72.8)   89.4 (88.1, 90.5) ¶
  **NPV**     99.4 (99.3, 99.4)   99.3 (99.2, 99.3)   99.7 (99.6, 99.7)\*    99.5 (99.5, 99.6)   99.3 (99.2, 99.3) ¶
  **ACC**     99.0 (99.0, 99.1)   98.8 (98.8, 98.9)   99.4 (99.3, 99.5)\*    99.1 (99.0, 99.2)   99.0 (98.9, 99.0)‡
  **Kappa**   80.7 (79.7, 81.7)   79.8 (78.6, 81.0)   83.5 (81.5, 85.5)      69.2 (66.6, 71.7)   84.2 (83.1, 85.3)

Discussion
==========

We report validity and reliability statistics for a novel ambulatory system to evaluate its capability to detect cough and demonstrate a high level of agreement and accuracy when compared to video surveillance for cough over an extended period. The system was well-tolerated and allowed for free movement throughout the monitoring facility. The system continuously monitors several cardio-pulmonary-activity variables, which allowed us to evaluate ventilatory strategies associated with coughing, which is one of its novel features.

The patient population in this study coughed with great frequency, which reflects the fact these were COPD patients who had a primary complaint of cough. At screening, patients were asked if they coughed ten times per day or more. Although all of the patients met this requirement, they had difficulty recalling how many cough bouts per day they experienced. As such, we did not predict that this population would cough with such a high frequency and, although the number of coughs was higher than anticipated, it was within the range of what has been reported previously \[[@B12]\].

Agreement between the LS system and video surveillance was excellent. Interestingly, we did observe that the nocturnal validation and agreement statistics, as well as differences between low and high respiratory rates, were statistically significantly different, although they differed only slightly in magnitude. These small, yet statistically significant, difference likely reflect the influence of the respiratory events (e.g., V~T~and F~b~) sample size during the recording period on the statistical power for these comparisons and is not clinically significant.

Objective cough assessment has been attempted on numerous previous occasions \[[@B6]-[@B8],[@B10],[@B12],[@B14]\]. Until now, a robust, accurate ambulatory system has failed to emerge. This is likely due to the fact that previous systems have attempted to identify cough with a single physiologic signal (e.g., sound). Sound-based technologies have been the primary means of cough assessment due to the audible sound that is generated during a cough \[28\]. These systems, however, are susceptible to a high false positive rate when ambient noise is prominent and are unable to distinguish cough-like sounds (e.g., throat clearing) from true cough. Hsu et al. (1994) \[[@B12]\] augmented sound analyses with concomitant intercostal electromyography (EMG) analyses and evaluated various clinical populations (e.g., normal controls, stable asthmatics and patients with daily, persistent & non-productive cough) and concluded that their system may be useful in the assessment of antitussive therapies. Hsu et al., however, did not present evidence of agreement by comparing their results to a reference standard.

There were three limitations to the study. First, the sample size was small. Sample size was limited by available resources to review the vast amount of video and LS data. Second, women (6/8) were over represented in the study, which was due to an inauspicious baseline imbalance. Third, the data were collected in a clinical setting due to the requirement for video monitoring equipment. However, patients were not confined to any one space and ambulated, spoke on the phone, dined and performed additional activities of daily living.

A substantial challenge in this study was the choice of a reference standard with which to evaluate the novel device. We chose video based on the fact that the source document (video) could be reviewed during the adjudication process if there was uncertainty with respect to the occurrence of a cough. Scoring the video in duplicate was an arduous task which likely increased the possibility of human error due to fatigue and it is possible that some coughs were missed. Events that were missed by both reviewers would not have been adjudicated, but identified by the LS system and therefore would have been inappropriately scored as a false-positive. Thus, these results are a conservative estimate of LS capabilities and may underestimate the predictive power of the device.

Conclusion
==========

We report data from a novel, ambulatory, multi-signal device that shows a high level of agreement and accuracy when compared to video/audio surveillance over an extended period and confirm its potential in the evaluation of antitussive therapies. The availability of a valid, robust ambulatory tool for quantifying cough will enable the determination of the minimal required reduction in cough to maximally improve patient HQRL, and open up a broad array of research questions both specific to cough and wherein cough may be an important covariate, comorbidity, or confounding factor.
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